
==== Front
Rheumatol Adv Pract
Rheumatol Adv Pract
rheumap
Rheumatology Advances in Practice
2514-1775
Oxford University Press

10.1093/rap/rkae021
rkae021
Original Article
AcademicSubjects/MED00010
Coalition for Health and Gender Equity (CHANGE)—a protocol for a global cross-sectional survey of health and gender equity in rheumatology
https://orcid.org/0000-0002-3083-4458
Khursheed Tayyeba Department of Rheumatology, Pakistan Institute of Medical Sciences, Islamabad, Pakistan

https://orcid.org/0000-0002-3504-2177
Ovseiko Pavel Radcliffe Department of Medicine, University of Oxford, Oxford, UK

Dyball Sarah Centre for Musculoskeletal Research, The University of Manchester, Manchester, UK

https://orcid.org/0000-0001-6247-0647
Nakashima Ran Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Gonzalez Ana Maria Arredondo Colombian Association of Rheumatology, Bogotá, Colombia
Department of Rheumatology, Faculty of Medicine, Fundación Universitaria de Ciencias de la Salud (FUCS), Bogotá, Colombia

Babini Alejandra Rheumatology Unit, Hospital Italiano de Cordoba, Cordoba, Argentina

Kalla Asgar Ali Department of Medicine, University of Cape Town, Cape Town, South Africa

Hill Catherine Rheumatology Unit, The Queen Elizabeth and Royal Adelaide Hospitals, Adelaide, SA, Australia
Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia

Danda Debashish Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India

Dey Dzifa Rheumatology Unit Department of Medicine and Therapeutics, Korle bu Teaching Hospital, University of Ghana Medical School, Accra, Ghana

Traboco Lisa Department of Medicine, Section of Rheumatology, St Luke’s Medical Center-Global City, Taguig, Philippines

Nikiphorou Elena Centre for Rheumatic Diseases, King’s College London, London, UK
Rheumatology Department, King’s College Hospital, London, UK

Harifi Ghita Department of Rheumatology, Mediclinic Parkview Hospital, Dubai, United Arab Emirates
Department of Medicine and Therapeutics, The Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China

Badshah Humeira Dr Humeira Badsha Medical Center, Dubai, United Arab Emirates

https://orcid.org/0000-0003-4402-5034
Hmamouchi Ihsane Clinical Epidemiology, Health Sciences College, International University of Rabat (UIR), Rabat, Morocco
Department of Rheumatology, Provincial Hospital of Temara, Temara, Morocco

Marie Von Feldt Joan University of Pennsylvania, Philadelphia, PA, USA

Farani Júlia Boechat Division of Rheumatology, Hospital Santa Casa de Misericórdia de Juiz de Fora, Juiz de Fora, Brazil

https://orcid.org/0000-0002-9107-3218
Andreoli Laura Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili di Brescia, Brescia, Italy

Guimarães Mariana Peixoto Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte, Brazil

Toro Gutiérrez Carlos Enrique General Director, Reference Center for Osteoporosis, Rheumatology and Dermatology, Pontifica Universidad Javeriana Cali, Cali, Colombia

Sieiro Santos Cristiana Department of Rheumatology, Complejo Asistencial Universitario de León, León, Spain

https://orcid.org/0000-0003-3137-8834
Duftner Christina Internal Medicine, Clinical Division of Internal Medicine II, Medizinische Universität Innsbruck, Innsbruck, Austria

https://orcid.org/0000-0002-6930-0517
Alpizar Rodriguez Deshire Research Unit, Mexican College of Rheumatology, Mexico City, Mexico

https://orcid.org/0000-0002-4479-7678
Ziadé Nelly Rheumatology Department, Hôtel-Dieu de France Hospital, Saint Joseph’s University, Beirut, Lebanon

Palominos Penélope Esther Rheumatology Division, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil

Haq Syed Atiqul Green Life Centre, Dhaka, Bangladesh

https://orcid.org/0000-0003-0684-9542
Bautista-Molano Wilson Rheumatology Division, University Hospital Fundación Santa Fé de Bogotá, Bogota, Colombia
School of Medicine, Universidad El Bosque, Bogotá, Colombia

https://orcid.org/0000-0002-0807-7139
Tanaka Yoshiya First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan

Gossec Laure Sorbonne Université, INSERM, IPLESP, AP-HP, Pitié-Salpetrière Hospital, Paris, France

Agarwal Vikas Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Wright Grace C Association of Women in Rheumatology; United Rheumatology, New York, NY, USA

https://orcid.org/0000-0002-4756-663X
Coates Laura Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK

https://orcid.org/0000-0003-2753-2990
Gupta Latika Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, The University of Manchester, Manchester, UK
Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK
Department of Rheumatology, City Hospital, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK

the CHANGE Study Group So Ho
Colunga-Pedraza Iris J
Chen Yi-Ming
Salim Babur
Vaidya Binit
Arredondo Gonzalez Ana Maria
Victoria Sadovici
Wang Qian
Akawatcharangura Phonpen
Siripaitoon Boonjing
Doskaliuk Bohdana
Sazliyana Shaharir Syahrul
Juge Pierre-Antoine
Klitz Uta
Mucke Johanna
Ravindran Vinod
Panagiotopoulos Alexandros
Colic Jelena
Bilgin Emre
Parodis Ioannis
de Hooge Manouk
Tα´lli Sandra
Magro Rosalie
Dourado Eduardo

Correspondence to: Latika Gupta, Division of Musculoskeletal and Dermatological Sciences, Centre for Musculoskeletal Research, School of Biological Sciences, The University of Manchester, Manchester, UK. E-mail: drlatikagupta@gmail.com
L.C. and L.G. contributed equally.

See supplementary material available at Rheumatology Advances in Practice online for a list of the authors part of the CHANGE Study Group and their affiliations.

2024
10 2 2024
10 2 2024
8 2 rkae02105 12 2023
31 12 2023
29 3 2024
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

Abstract

Objectives

The primary aim of the CHANGE survey is to determine the current state of gender equity within rheumatology, and secondarily, to review the physician perspective on bullying, harassment and equipoise of opportunities within rheumatology.

Methods

The CHANGE e-survey is a cross-sectional self-reported questionnaire adapted from EULAR’s gender equity in academic rheumatology task force. The survey was launched in January 2023; it is available in six languages and distributed widely via rheumatology organizations and social media. Eligible participants include rheumatologist physicians and rheumatology health-care professionals. Survey responses will undergo descriptive analysis and inter-group comparison aiming to explore gender-based discrimination using logistic regression, with subgroup analyses for country/continent variations.

Conclusion

This e-survey represents a comprehensive global initiative led by an international consortium, aimed at exploring and investigating the gender-related disparities and obstacles encountered by rheumatologists and rheumatology health-care professionals across diverse communities and health-care environments. By pursuing this initiative, we aim to take the broader rheumatology community a step closer to understanding the underlying origins of inequities and their determinants. Such insights are pivotal in identifying viable interventions and strategies to foster gender equity within the field. Ultimately, our collective objective is to ensure equitable access to opportunities for every individual, irrespective of gender, thereby promoting inclusivity and fairness across the entire spectrum of professional practice and career development.

rheumatology
professionals
gender
equity
women
surveys and questionnaires
International League of Associations for Rheumatology
==== Body
pmcKey messages Coalition for Health and Gender Equity (CHANGE) is a global network of rheumatology professionals.

The CHANGE group assesses the state of equity in academia, practice and leadership globally.

The group hopes that the results will inform evidence-based rheumatology guidelines to foster gender equity in global initiatives.

Introduction

Gender equity refers to the principle of ensuring fairness, impartiality and justice in distributing resources, opportunities and benefits among individuals of all genders. There is growing attention to gender inequity within the rheumatology workforce, with persistent challenges in achieving pay parity, career progression and access to leadership roles [1–3]. The United Nations’ 2030 Agenda for Sustainable Development has called for ‘women’s full and effective participation and equal opportunities for leadership at all levels of decision-making in political, economic and public life’ [4]. Gender disparities in pay and progression are reflected across academia, clinical practice and leadership settings [5].

It is imperative that firstly, the extent of inequity is assessed, and that secondly, the requirements for career support to accelerate progression in professional and academic rheumatology are determined. There is a paucity of data on the physicians’ perspective of gender equity within the rheumatology profession. A large, multinational survey is a beneficial method for assessing gender equity in rheumatology, because it allows for a comprehensive analysis of diverse perspectives and experiences across different regions, providing valuable insights into potential disparities and opportunities for improvement in the field.

For this purpose, a global group of experts with representation from different leagues and organizations conceptualized a global network of rheumatology professionals – Coalition for Health and Gender Equity (CHANGE). The gender equity project being conducted by CHANGE is endorsed by several regional and national rheumatology leagues, including the Association for Women in Rheumatology (AWIR), the African League against Rheumatism (AFLAR), the Asia-Pacific League of Associations for Rheumatology (APLAR), ArLAR (Arab League of Associations for Rheumatology) and the Pan-American League of Association for Rheumatology (PANLAR) and American College of Rheumatology (ACR), and is supported by an International League of Associations for Rheumatology (ILAR) grant.

The primary aim of this study is to determine the current state of gender equity within rheumatology, and secondarily, to review the physician perspective on bullying, harassment and equipoise of opportunities within rheumatology. Finally, we review proposed interventions to mitigate any perceived inequity.

Methods

An extensive survey evaluating the current status of gender equity in global rheumatology was developed to evaluate three key domains: academia, clinical practice and leadership. The CHANGE survey is a cross-sectional self-reported questionnaire that investigates gender equity among rheumatologists and allied health professionals to develop potential solutions to the professional challenges raised. The survey is designed to assess the current state of perceived equity and unmet needs faced by the rheumatology workforce, identify proposed solutions, and potentially, develop a framework to address the identified problems. The survey has undergone pilot testing, validation and vetting, followed by translations into eight languages.

Survey design

The survey comprises 38 items covering gender-based discrimination, work–life balance, potential interventions for career support, and professional development (Supplementary Data S1, available at Rheumatology Advances in Practice online). It includes 15 multiple-choice questions with single-answer options and 12 with multiple-answer options. Informed consent is obtained in the introduction to the survey. The survey was launched on a survey-hosting website (www.surveymonkey.com). In addition, considering cultural sensitivities, the name and certain survey items are modified in the Arabic version (Supplementary Data S1, available at Rheumatology Advances in Practice online) to exclude questions on sexuality and bullying.

Sample size estimation

A pragmatic approach is taken for participant recruitment to allow a broader participation and representation of respondents. Given the complexity of the topic and the potential for unequal gender distribution among respondents, the focus is on collecting real-world data from a diverse range of participants, acknowledging that individual perspectives and experiences could vary widely. This approach aims to capture a comprehensive view of gender equity within the rheumatology profession.

Pilot testing and validation

Three rheumatologists (L.G., L.C. and M.P.G.) and a sociologist (P.O.) reviewed the questions for face validity and confirmed them to represent the intended content. The survey was pilot tested with multiple rounds of dummy completion by the members of the steering committee of the CHANGE group, who critically evaluated the questionnaire. The median (interquartile range) time to complete the survey was 5 (3–6) min. The survey was designed such that respondents could modify the survey responses before submission, but no responses could be modified after final submission.

Population selection

Eligible participants include rheumatologist physicians and rheumatology health-care professionals (HCPs), including nurses, physiotherapists, occupational therapists and other HCPs specializing in rheumatology. Rheumatologists and HCPs directly involved in the care of patients with rheumatic diseases of any age, gender, region and practice setting will be eligible. Convenience, snowball and target sampling approaches will be used to maximize responses and participation. For this purpose, rheumatologists and HCPs who are members of national societies will be approached through their societies, when the latter would endorse the study and agree to approach their members, assuming that most target rheumatologists are members of the national societies.

Consent and ethics approval

Ethics approval was obtained from the ethics review board of Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India (226014) according to local regulations. A statement explaining the purpose of the study is included in the cover letter, providing the participants with the option to consent or decline participation. No incentives are offered for survey completion. The Committee on Publication Ethics (COPE) guidelines are adhered to for data collection [6], and the Checklist for Reporting Results of Internet e-surveys (CHERRIES) and Consensus-Based Checklist for Reporting of Survey Studies (CROSS) will be used to report the data [7–9].

Survey dissemination

The survey is distributed through various channels, including email lists of regional and national rheumatology leagues, including AWIR, AFLAR, APLAR, ArLAR and PANLAR and several national rheumatology organizations. Additionally, is disseminated through social media platforms, including Twitter, WhatsApp groups, Facebook, LinkedIn pages and the personal networks of the investigators. The survey was launched online in January 2023 and is currently ongoing.

Statistical analysis

Data obtained from the survey will be downloaded from the hosting website. These data will undergo descriptive analysis and inter-group comparison using SPSS v.28 for Windows (SPSS Inc., Chicago, IL, USA). The primary outcome of this study is to investigate the difference in discrimination experienced by all genders across the profession, measured by the presence of perceived discrimination in any domain using logistic regression. Subgroup analyses will investigate variance by country/continent. Continuous variables with normal distribution will be presented as the mean (s.d.); non-normal variables will be reported as the median (interquartile range). The means of two continuous normally distributed variables will be compared by Student’s independent-samples t-test. The Mann–Whitney U test and the Kruskal–Wallis test will be used to compare means of two and three or more groups of variables non-normally distributed. The frequencies of categorical variables will be compared using Pearson χ2 or Fisher’s exact test, as appropriate. A value of P < 0.05 will be considered significant.

Future analysis from the dataset

Subgroup analysis based on geographical location, practice type and other relevant factors will be undertaken to understand the needs of female rheumatologists and the unmet needs in their professional careers. The analyses from the CHANGE survey dataset will inform evidence-based guidelines within rheumatology practice.

Dissemination of outcomes

The study findings will be disseminated in a peer-reviewed journal and presented as abstracts in scientific conferences. In addition, a concise summary of study findings will be provided to participants upon request.

Discussion

There are pressing challenges affecting the global rheumatology workforce. These include a shortage of human resources, pay disparities, prolonged working hours and burnout [10], which result in decreased productivity in the health-care systems. Research suggests possible gender differences in how practitioners experience and respond to these challenges [10]. Inequity in health systems results in job dissatisfaction, loss of confidence and reduced earnings, whereas promoting equity results in increased productivity of health systems. This allows better patient care, equal opportunities and financial growth to occur [11]. In addition to the aforementioned factors, there are glass ceilings and undefined barriers to academic and professional development [12]; for example, reduced visibility of opportunities appears to be a key factor impacting the advancement of women to editorial board positions [13]. CHANGE aims to quantify and explore such barriers, highlight the unmet needs of rheumatology professionals, and suggest interventions for overcoming these obstacles.

Gender equity is essential for a fair and contented society. Evidence suggests that fostering equity, as indicated by a review of various studies, ensures policies that cater to the well-being of all [14]. Organizations can boost the health of patients positively. Advancing women in medicine is linked with advancing women’s health [15]. Using the research talent of individuals irrespective of their gender allows research potential to be maximized to benefit patients’ health [16]. Therefore, working towards equity is for society’s advancement and well-being. Not only does it empower women, but it also benefits men [17]. Grass-root-level changes have the potential to bring about major improvements in public health, akin to World Health Organization initiatives to recommend hand washing to reduce surgery-related mortality.

There is evidence that the global rheumatology workforce is attaining parity in many regions [18–21]; however, there are gaps in academic excellence and research productivity, for instance in attaining senior authorship positions and publishing in high-impact journals [22]. Moreover, there remain disparities in editorial board positions [13, 23], rheumatology peer review process, attainment of awards [24] and speaker representation at international rheumatology conferences [25–27]. Preliminary data suggest that substantial gender gaps exist within leadership positions in both global [28] and regional rheumatology leagues [29]. The reasons for this have not been elucidated and might relate to limited visibility of opportunities, selection processes or implicit biases. Trends might also vary owing to cultural constructs [27]. CHANGE, as a globally reaching survey, will review these questions. Hence, there are wide-ranging challenges that need to be addressed to ensure equity in academic and professional development besides addressing the gender pay gap in rheumatology practice [12].

Several initiatives have accelerated equity and aided professional development. The EULAR gender equity task force (GEAR) in rheumatology is an example of a comprehensive intervention programme on gender equity [30, 31], which has highlighted the gender differences in career advancement in academic rheumatology [31]. The Association of Women in Rheumatology (AWIR), Rheumatology Donne (ReDO) and Female Advancement In Rheumatology (FAIR) are further examples of such initiatives with a focus on advocacy, in addition to establishing an inter-institutional network of rheumatologists to highlight and address the unmet clinical and scientific needs of women [12]. There remains a need for a global initiative that highlights and addresses the unmet clinical and scientific needs of female rheumatologists around the globe.

Conclusion

The CHANGE survey has been designed to provide real-world data on gender equity in rheumatology today and assess the unmet needs of women in rheumatology. These insights will inform global rheumatology leagues, organizations and workplaces. The findings from the CHANGE survey are anticipated to be available by the end of 2024, aiming to contribute to evidence-based policies and recommendations that enhance the productivity and satisfaction of the global rheumatology workforce.

Supplementary Material

rkae021_Supplementary_Data

Acknowledgements

The authors thank the Japan College of Rheumatology (JCR), JCR Gender and Youth Equality Committee, French Rheum Association (REF), Italian Rheumatology Society, Openreuma, Spanish Rheumatology Society (SER), Portuguese Rheumatology Society (SPR), Greek Rheumatology society, Norwegian Society for Rheumatology, ERN Reconnect, Australian Rheumatology Society, OMERACT, and Italian Rheumatology Society for their contribution to disseminating this survey. The authors wish to thank all members of the CHANGE Study Group (Supplementary Data S2, available at Rheumatology Advances in Practice online) for their invaluable role in the data collection.

Coalition for Health and Gender Equity (CHANGE) Study Group: Ho So, Iris J. Colunga-Pedraza, Yi-Ming Chen, Babur Salim, Binit Vaidya, Ana Maria Arredondo Gonzalez, Sadovici Victoria, Qian Wang, Phonpen Akawatcharangura, Boonjing Siripaitoon, Bohdana Doskaliuk, Syahrul Sazliyana Shaharir, Pierre-Antoine Juge, Uta Klitz, Johanna Mucke, Vinod Ravindran, Alexandros Panagiotopoulos, Jelena Colic, Emre Bilgin, Ioannis Parodis, Manouk de Hooge, Sandra Tάlli, Rosalie Magro, Eduardo Dourado.

Supplementary material

Supplementary material is available at Rheumatology Advances in Practice online.

Data availability

The data underlying this article are available in the article and in its online supplementary material.

Contribution statement

Conceptualization: L.G. and L.C. Data curation: all authors. Formal analysis: T.K., L.G., S.D. and P.O. Funding acquisition: L.C. and L.G. Investigation: L.G., L.C. and T.K. Methodology: L.G., L.C. and T.K. Software: L.G. Validation: V.A., L.G. and L.C. Visualization: L.C. and L.G. Writing—original draft: T.K., L.G., S.D. and P.O. Writing—review and editing: all authors. All the authors acknowledge their contribution and take full responsibility for the integrity and accuracy of the work presented. No artificial intelligence software was used in writing or editing the present manuscript.

Funding

This study has received funding from the International League of Associations for Rheumatology (ILAR) grant.

Disclosure statement: E.N. has received speaker honoraria/participated in advisory boards for UCB, Fresenius, Celltrion, Pfizer, Sanofi, Gilead, Galapagos, AbbVie and Lilly and holds research grants from Pfizer and Lilly. N.Z. has received speaker fees, advisory board fees and research grants from Pfizer, Roche, Abbvie, Eli Lilly, NewBridge, Sanofi-Aventis, Boehringer Ingelheim, Janssen and Pierre Fabre; none is related to this manuscript. Y.T. has received speaker fees and/or honoraria from Eli Lilly, AstraZeneca, Abbvie, Asahikasei, Gilead, Chugai, Behringer-Ingelheim, GlaxoSmithKline, Eisai, Taisho, Bristol-Myers, Pfizer and Taiho and received research grants from Asahikasei, Mitsubishi-Tanabe, Eisai, Chugai and Taisho. The remaining authors have declared no conflicts of interest.

Disclaimer: No part of this manuscript has been copied or published elsewhere in whole or in part.
==== Refs
References

1 Boniol M , McIsaacM et al Gender equity in the health workforce: analysis of 104 countries. Geneva: World Health Organization, 2019. https://www.who.int/publications/i/item/gender-equity-in-the-health-workforce-analysis-of-104-countries (24 February 2024, date last accessed).
2 World Health Organization . Delivered by women, led by men: a gender and equity analysis of the global health and social workforce. (Human Resources for Health Observer Series No. 24). Geneva: World Health Organization, 2019. https://www.who.int/publications/i/item/9789241515467 (24 February 2024, date last accessed).
3 World Health Organization . Closing the leadership gap: gender equity and leadership in the global health and care workforce. Policy action paper. Geneva: World Health Organization, 2021. https://www.who.int/publications/i/item/9789240025905 (24 February 2024, date last accessed).
4 Marmot M , BellR. The sustainable development goals and health equity. Epidemiology (Cambridge, Mass) 2018;29 :5–7.29053554
5 Edmunds LD , OvseikoPV, ShepperdS et al Why do women choose or reject careers in academic medicine? A narrative review of empirical evidence. Lancet 2016;388 :2948–58.27105721
6 Wager E. The Committee on Publication Ethics (COPE): objectives and achievements 1997–2012. La Presse Médicale 2012;41 :861–6.22727914
7 Eysenbach G. Correction: improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res 2012;14 :e8. 10.2196/jmir.2042.
8 Gaur PS , ZimbaO, AgarwalV, GuptaL. Reporting survey based studies—a primer for authors. J Kor Med Sci 2020;35 :e398.
9 Sharma A , Minh DucNT, Luu Lam ThangT et al A Consensus-based checklist for Reporting of Survey Studies (CROSS). J Gen Intern Med 2021;36 :3179–87.33886027
10 Khursheed T , SharifM, KhanMS et al Burnout in South Asian rheumatologists in the COVID-19 pandemic: an online survey. Rheumatol Int 2023;43 :1143–50.36917244
11 World Health Organization . Gender, equity, and leadership in the global health and social workforce. Geneva: World Health Organization. https://www.who.int/publications/i/item/9789240025905 (24 February 2024, date last accessed).
12 Andreoli L , OvseikoPV, HassanN et al Gender equity in clinical practice, research, and training: where do we stand in rheumatology? Joint Bone Spine 2019;86 :669–72.31220622
13 Day J , OvseikoP, KhursheedT et al Factors impacting women’s advancement to positions on editorial boards of rheumatology journals. Rheumatology (Oxford) 2023;62 :e260–2.36944272
14 Downs JA , ReifLK, HokororoA, FitzgeraldDW. Increasing women in leadership in global health. Acad Med 2014;89 :1103–7.24918761
15 Carnes M , MorrisseyC, GellerSE. Women’s health and women’s leadership in academic medicine: hitting the same glass ceiling? J Women's Health (2002) 2008;17 :1453–62.
16 Penny M , JeffriesR, GrantJ, DaviesSC. Women and academic medicine: a review of the evidence on female representation. J R Soc Med 2014;107 :259–63.24739380
17 Audette AP , LamS, O’ConnorH, RadcliffB. (E)quality of life: a cross-national analysis of the effect of gender equality on life satisfaction. J Happiness Stud 2019;20 :2173–88.
18 Battafarano DF , DitmyerM, BolsterMB et al 2015 American College of Rheumatology workforce study: supply and demand projections of adult rheumatology workforce, 2015–2030. Arthritis Care Res 2018;70 :617–26.
19 Serna-Peña G , Colunga-PedrazaIJ, Galarza-DelgadoDÁ et al AB0871-HPR women in rheumatology: barriers, limitations, and gender inequality. Ann Rheum Dis 2021;80 :1459.2.
20 Dey D , ParukF, ModyGM et al Women in rheumatology in Africa. Lancet Rheumatol 2022;4 :E657–60.38265961
21 Hmamouchi I , ZiadéN, El KibbiL, PolyakovS, ArayssiT. Promising authorship by Arab women in rheumatology. Lancet Rheumatol 2022;4 :e660–2.38265962
22 Adami G , BeniniC, VantaggiatoE et al Gender disparity in authorship of guidelines and recommendations in rheumatology. Ann Rheum Dis 2020;79 :1122–3.32102797
23 Ovseiko PV , AfsarAP, FazalZZ, CoatesLC, GuptaL. Gender representation on editorial boards of rheumatology journals. Lancet Rheumatol 2022;4 :e663–4.38265963
24 Halling T , DreherA, MambreyV et al Prize trends in rheumatology: the gender award gap. Lancet Rheumatol 2022;4 :e655–6.38265960
25 Hassan N , van MensLJ, KiltzU et al Gender equity in academic rheumatology: is there a gender gap at European rheumatology conferences? RMD Open 2022;8 :e002131.35246471
26 Monga K , LiewJ. Gender gap in rheumatology: speaker representation at annual conferences. Ann Rheum Dis 2022;81:e238.
27 Traboco LS , Zamora-AbrahanG, ReyesSM et al Gender parity perspectives in Asia Pacific: a descriptive analysis of Philippine rheumatology conferences. Rheumatol Int 2023;43 :1135–41.36912939
28 Khursheed T , HarifiG, OvseikoPV et al Is there a gender gap in global rheumatology leadership? J Rheumatol 2022;62 :e107–8.
29 Khursheed T , OvseikoPV, HarifiG et al Gender equity in rheumatology leadership in the Asia-Pacific. Rheumatol Adv Pract 2022;6 :rkac087.36382268
30 Ovseiko PV , GossecL, AndreoliL et al THU0580 EULAR task force on gender equity in academic rheumatology: preliminary survey findings. Ann Rheum Dis 2020;79 :531.2–2.
31 Ovseiko PV , GossecL, AndreoliL et al Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force. RMD Open 2022;8 :e002518.35940824
